A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes.

Nature 2014 Aug 18;512(7513):190-3. Epub 2014 Jun 18.

1] The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark [2] Faculty of Health Sciences, University of Southern Denmark, 5000 Odense, Denmark.

The Greenlandic population, a small and historically isolated founder population comprising about 57,000 inhabitants, has experienced a dramatic increase in type 2 diabetes (T2D) prevalence during the past 25 years. Motivated by this, we performed association mapping of T2D-related quantitative traits in up to 2,575 Greenlandic individuals without known diabetes. Using array-based genotyping and exome sequencing, we discovered a nonsense p.Arg684Ter variant (in which arginine is replaced by a termination codon) in the gene TBC1D4 with an allele frequency of 17%. Here we show that homozygous carriers of this variant have markedly higher concentrations of plasma glucose (β = 3.8 mmol l(-1), P = 2.5 × 10(-35)) and serum insulin (β = 165 pmol l(-1), P = 1.5 × 10(-20)) 2 hours after an oral glucose load compared with individuals with other genotypes (both non-carriers and heterozygous carriers). Furthermore, homozygous carriers have marginally lower concentrations of fasting plasma glucose (β = -0.18 mmol l(-1), P = 1.1 × 10(-6)) and fasting serum insulin (β = -8.3 pmol l(-1), P = 0.0014), and their T2D risk is markedly increased (odds ratio (OR) = 10.3, P = 1.6 × 10(-24)). Heterozygous carriers have a moderately higher plasma glucose concentration 2 hours after an oral glucose load than non-carriers (β = 0.43 mmol l(-1), P = 5.3 × 10(-5)). Analyses of skeletal muscle biopsies showed lower messenger RNA and protein levels of the long isoform of TBC1D4, and lower muscle protein levels of the glucose transporter GLUT4, with increasing number of p.Arg684Ter alleles. These findings are concomitant with a severely decreased insulin-stimulated glucose uptake in muscle, leading to postprandial hyperglycaemia, impaired glucose tolerance and T2D. The observed effect sizes are several times larger than any previous findings in large-scale genome-wide association studies of these traits and constitute further proof of the value of conducting genetic association studies outside the traditional setting of large homogeneous populations.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13425DOI Listing
August 2014
43 Reads

Publication Analysis

Top Keywords

plasma glucose
12
type diabetes
8
protein levels
8
serum insulin
8
hours oral
8
heterozygous carriers
8
association studies
8
glucose load
8
glucose
8
oral glucose
8
homozygous carriers
8
marginally lower
4
lower concentrations
4
concentrations fasting
4
carriers marginally
4
carriers homozygous
4
genotypes non-carriers
4
non-carriers heterozygous
4
frequency 17%
4
fasting plasma
4

References

(Supplied by CrossRef)

ME Jørgensen et al.
Diabetes Care 2002

RA Scott et al.
Nature Genet. 2012

AP Morris et al.
Nature Genet. 2012

AK Manning et al.
Nature Genet. 2012

T Rafnar et al.
Nature Genet. 2011

ME Jørgensen et al.
Diabetes Care 2013

BF Voight et al.
PLoS Genet. 2012

J Marchini et al.
Nature Genet. 2004

P Bjerregaard et al.
Int. J. Circumpolar Health 2003

M Gutt et al.
Diabetes Res. Clin. Pract. 2000

H Cederberg et al.
Diabetes Care 2010

Similar Publications